AK

Ariel Kantor

Ariel Kantor


Senior Vice President, Head of Business & Corporate Development



Professional Overview
Ariel Kantor is an accomplished business development and strategy executive with a track record of driving growth and innovation in the life sciences industry. As the Senior Vice President and Head of Business & Corporate Development at ReCode Therapeutics, she leads the company's strategic initiatives, including mergers and acquisitions, licensing, and partnership opportunities. Kantor's deep expertise in biotech and pharmaceuticals, combined with her entrepreneurial mindset, enables her to identify and capitalize on emerging market trends and technology advancements.

Experience Summary

Current Role
In her current role at ReCode Therapeutics, Kantor is responsible for spearheading the company's business development strategy and executing on high-impact transactions. She has played a pivotal role in securing strategic partnerships and licensing deals that have expanded ReCode's pipeline and accelerated the commercialization of its innovative therapeutic platforms. Kantor's leadership has been instrumental in positioning ReCode as a leading player in the rapidly evolving gene therapy and precision medicine space.

Career Progression
Prior to her current role, Kantor served as the Vice President and Director of Business Development at ReCode Therapeutics, where she successfully executed multiple licensing agreements and collaborative research projects. Earlier in her career, she gained valuable experience as an Entrepreneur-in-Residence at Oxford Science Enterprises, where she provided strategic guidance to early-stage biotech startups, and as an investment banker in the healthcare sector at Evercore. Kantor's diverse background and industry expertise have enabled her to make significant contributions throughout her career.

Academic Background
Kantor holds a Ph.D. in Genomics and Computational Biology from Duke University, where she conducted groundbreaking research at the Center for Genomic and Computational Biology. Her academic achievements and deep scientific understanding have been instrumental in her ability to effectively bridge the gap between technological innovation and commercial success.

Areas of Expertise
  • Strategic business development and corporate partnership negotiations

  • Mergers, acquisitions, and integration management

  • Licensing and transaction structuring

  • Evaluation and due diligence of emerging technologies and trends

  • Cross-functional leadership and collaboration

  • Venture capital and private equity fundraising


Professional Impact
Under Kantor's leadership, ReCode Therapeutics has secured several high-profile partnerships and licensing deals, expanding the company's technology platform and pipeline. Her ability to identify and capitalize on market opportunities has contributed to ReCode's growth and positioned the company as a leading player in the gene therapy and precision medicine space. Kantor's entrepreneurial mindset and industry expertise have been invaluable in driving innovation and creating value for ReCode's stakeholders.

Conclusion
Ariel Kantor is a seasoned business development and strategy executive with a proven track record of success in the life sciences industry. Her strong technical background, coupled with her strategic and collaborative approach, make her a valuable asset to ReCode Therapeutics as the company continues to push the boundaries of gene therapy and precision medicine. Kantor's commitment to innovation and her ability to identify and capitalize on emerging market trends position her as a dynamic and forward-thinking leader in the industry.